Effects of antidepressants in rats trained to discriminate the beta-2 adrenergic agonist clenbuterol
Abstract
The ability of indirectly acting agonists such as norepinephrine uptake inhibitors, serotonin reuptake inhibitors, and atypical antidepressants to substitute for clenbuterol, a beta-2 adrenergic agonist, was examined in rats trained to discriminate 0.03 mg/kg clenbuterol and saline using a fixed-ratio 10 (FR 10) schedule with water reinforcement. The beta-2 selective adrenergic agonist clenbuterol produced an orderly dose-response relationship, and its discriminative stimulus effects were antagonized by the beta-adrenergic antagonist propranolol. It was found that the effects of tricyclic antidepressants and selective norepinephrine uptake inhibitors did not generalize to the discriminative stimulus effects of clenbuterol, with the exception of high doses of protriptyline. Moreover, compounds from other drug classes, including fluoxetine and phenelzine, did not substitute for clenbuterol. Atypical antidepressants, such as trazodone, rolipram, and bupropion also did not engender drug-appropriate responding. Prenalterol and dobutamine, both purported to be beta-1 adrenergic receptor agonists, partially substituted for clenbuterol, but at relatively high doses. The present results show that the antidepressants tested do not share discriminative stimulus effects with clenbuterol, a beta-2 adrenergic agonist.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
α3β4-containing nAChRs are believed to play a major role in nicotine-evoked NE release from the hippocampus.
“α3β4-containing nAChRs are believed to play a major role in nicotine-evoked NE release from the hippocampus [220, 221].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [220]
Cites
Draper, N. R., & Smith, H. (2005) · Technometrics · doi:10.1198/tech.2005.s303 · Cited by 17,993 · see citing works
Bain, L. J., Draper, N. R., & Smith, H. (1967) · Technometrics · doi:10.2307/1266329 · Cited by 3,327 · see citing works
Minneman, K. P., Hegstrand, L. R., & Molinoff, P. B. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11387-4 · Cited by 253 · see citing works
Wachtel, H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90239-3 · Cited by 242 · see citing works
Ordway, G. A., Gambarana, C., & Frazer, A. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20043-x · Cited by 94 · see citing works
State notation of behavioral procedures
Snapper, A. G., Kadden, R. M., & Inglis, G. B. (1982) · Behavior Research Methods · doi:10.3758/bf03203225 · Cited by 92 · see citing works
Progress in Catecholamine Research
COUPLAND, R. E. (1990) · Europe PMC (PubMed Central) · Cited by 83 · see citing works
Mendels, J. (1970) · Medical Entomology and Zoology · Cited by 78 · see citing works
Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat.
Ordway, G. A., O’Donnell, J. M., & Frazer, A. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00323-4 · Cited by 63 · see citing works
Conway, P. G., Tejani‐Butt, S. M., & Brunswick, D. J. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00191-0 · Cited by 51 · see citing works
O’Donnell, J. M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00358-1 · Cited by 37 · see citing works
O’Donnell, J. M., & Frazer, A. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23304-3 · Cited by 36 · see citing works
O’Donnell, J. M., Frith, S. A., & Wilkins, J. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22769-0 · Cited by 36 · see citing works
Agonist interactions with beta adrenergic receptors in rat brain.
O’Donnell, J. M., Wolfe, B. B., & Frazer, A. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21887-0 · Cited by 34 · see citing works
O’Donnell, J. M. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12575-5 · Cited by 29 · see citing works
Imipramine as a discriminative stimulus.
Zhang, L., & Barrett, J. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20482-7 · Cited by 28 · see citing works
Characterization of the bupropion cue in the rat: Lack of evidence for a dopaminergic mechanism
Blitzer, R. D., & Becker, R. E. (1985) · Psychopharmacology · doi:10.1007/bf00428409 · Cited by 27 · see citing works
A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine
Finnegan, K. T., Terwilliger, M. M., Berger, P. A., Hollister, L. E., & Csernansky, J. G. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90158-0 · Cited by 26 · see citing works
Pharmacologic Mechanisms of Action of Antidepressants
Frazer, A., & Conway, P. G. (1984) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30751-2 · Cited by 26 · see citing works
Heydorn, W. E., Frazer, A., & Weiss, B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7176 · Cited by 24 · see citing works
Pharmacological Characterization of the Discriminative Stimulus Effects of Clenbuterol in Rats
O’Donnell, J. J. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00038-5 · Cited by 20 · see citing works
Matsumoto, K., Ojima, K., Ohta, H., & Watanabe, H. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90450-2 · Cited by 19 · see citing works
Discriminative stimulus control with imipramine: Transfer to other anti-depressants
Schechter, M. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90074-6 · Cited by 17 · see citing works
Inhibitory effect of noradrenaline uptake inhibitors on contractions of rat aortic smooth muscle
Huang, Y. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15223.x · Cited by 17 · see citing works
Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement.
McElroy, J. F., & O’Donnell, J. M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22283-2 · Cited by 16 · see citing works
Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram
Schneider, H. H. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00296-u · Cited by 15 · see citing works
Rolipram forms a potent discriminative stimulus in drug discrimination experiments in rats
Ortmann, R., & Meisburger, J. G. (1986) · Psychopharmacology · doi:10.1007/bf00174358 · Cited by 15 · see citing works
O’Donnell, J. M. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90164-5 · Cited by 14 · see citing works
Reserpine-induced hypothermia: Participation of β1 and β2 adrenergic receptors
Francès, H., & Simon, P. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90471-0 · Cited by 14 · see citing works
Facilitation of norepinephrine release from cerebral cortex is mediated by β2-adrenergic receptors
Murugaiah, K., & O’Donnell, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02173-g · Cited by 14 · see citing works
Peripheral mediation of effects of clenbuterol on locomotor and investigatory behavior in rats
Geyer, M. A., & Frampton, S. F. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(88)80002-9 · Cited by 13 · see citing works
Frazer, A., Ordway, G. A., O’Donnell, J. M., Vos, P., & Wolfe, B. B. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513361.ch10 · Cited by 12 · see citing works
McElroy, J. F., Stimmel, J. J., & O’Donnell, J. M. (1989) · Psychopharmacology · doi:10.1007/bf00443423 · Cited by 7 · see citing works
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00178.x · Cited by 259 · see citing works
Carroll, F. I., Blough, B. E., Mascarella, S. W., Navarro, H. A., Eaton, J. B., Lukas, R. J., & Damaj, M. I. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9017465 · Cited by 119 · see citing works
O’Donnell, J. M., Marek, G. J., & Seiden, L. S. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.018 · Cited by 83 · see citing works
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
Pattij, T., Schetters, D., Schoffelmeer, A. N. M., & van Gaalen, M. M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2405-2 · Cited by 46 · see citing works
“Although dobutamine has an approximately tenfold higher affinity for β1-adrenoceptors over β2-adrenoceptors (Williams and Bishop 1981), it is possible that at this dose the beneficial effects of this drug on visuospatial attention are mediated through β2-adrenoceptor activation (Baker 2010; Makhay and O’Donnell 1999).”
Crissman, A. M., Makhay, M. M., & O’Donnell, J. M. (2001) · Psychopharmacology · doi:10.1007/s002130000618 · Cited by 25 · see citing works
Effects of Antidepressants in Rats Trained to Discriminate Centrally Administered Isoproterenol
Crissman, A. M., & O’Donnell, J. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034686 · Cited by 20 · see citing works
Zhang, H., Huang, Y., & O’Donnell, J. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1512-0 · Cited by 19 · see citing works
Discriminative Stimulus Properties of S(−)-Nicotine: “A Drug for All Seasons”
Rosecrans, J. A., & Young, R. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_3 · Cited by 12 · see citing works
Millan, M. J., & Dekeyne, A. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007309 · Cited by 9 · see citing works
- Authors
- Makhay, M. M., & O’Donnell, J. M.
- Affiliations
- Louisiana State University (US)
- Corresponding author
- Makhay, Malath M
- ORCID
- O’Donnell, James M
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 1999-06
- Volume
- 63
- Issue
- 2
- Pages
- 319-324
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2078982829
- Cited by
- 10
- References
- 36
- Citations by year
- 2017: 1
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- clenbuterol, beta2-adrenergic agonists, antidepressants, discriminative stimulus effects, drug substitution, propranolol, tricyclic antidepressants, selective norepinephrine reuptake inhibitors, atypical antidepressants, beta-adrenoceptor antagonism, prenalterol, dobutamine
- MeSH terms
- Adrenergic beta-Agonists, Animals, Antidepressive Agents, Antidepressive Agents, Tricyclic, Clenbuterol, Conditioning, Operant, Discrimination Learning, Male, Receptors, Adrenergic, beta, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review